{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T19:06:14Z","timestamp":1779217574934,"version":"3.51.4"},"reference-count":85,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019533","name":"Moderna, Inc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019533","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/21645515.2026.2662118","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T18:17:16Z","timestamp":1779214636000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Safety of COVID-19 mRNA-1273 booster doses in Asian populations: A literature review of post-marketing observational studies"],"prefix":"10.1080","volume":"22","author":[{"given":"Chris","family":"Clarke","sequence":"first","affiliation":[{"name":"Moderna","place":["Melbourne, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daina","family":"Esposito","sequence":"additional","affiliation":[{"name":"Moderna, Inc","place":["Cambridge, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9215-3541","authenticated-orcid":false,"given":"Veronica","family":"Urdaneta","sequence":"additional","affiliation":[{"name":"Moderna, Inc","place":["Cambridge, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piyali","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Moderna","place":["Singapore, Singapore"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda K.","family":"Buttery","sequence":"additional","affiliation":[{"name":"Moderna","place":["Melbourne, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"e_1_3_3_2_1","unstructured":"WHO. COVID-19 dashboard. World Health Organization. 2023. https:\/\/data.who.int\/dashboards\/covid19\/vaccines."},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1429265"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-021-01480-7"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2024.2402955"},{"key":"e_1_3_3_6_1","unstructured":"Reuters. Japan health panel approves Moderna AstraZeneca COVID-19 vaccines [press release]. 2021. https:\/\/www.reuters.com\/world\/asia-pacific\/japan-likely-approve-astrazeneca-moderna-vaccines-nhk-2021-05-19\/."},{"key":"e_1_3_3_7_1","unstructured":"CNA. Moderna vaccine receives emergency authorization self-funded AZ vaccine supply remains uninterrupted [press release]. 2021. https:\/\/www.cna.com.tw\/news\/firstnews\/202105050200.aspx."},{"key":"e_1_3_3_8_1","unstructured":"Yonhap News Agency. Moderna COVID-19 vaccine gets final nod in S. Korea [press release]. 2021. https:\/\/en.yna.co.kr\/view\/AEN20210521005500320."},{"key":"e_1_3_3_9_1","unstructured":"THE STRAITS TIMES. Philippines clears Moderna COVID-19 vaccine for emergency use [press release]. 2021. https:\/\/www.straitstimes.com\/asia\/se-asia\/philippines-clears-moderna-covid-19-vaccine-for-emergency-use."},{"key":"e_1_3_3_10_1","unstructured":"U.S. Food and Drug Administration. Emergency Use Authorization (EUA) amendment for an unapproved product review Memorandum. 2021. 2025 Oct 23. https:\/\/www.fda.gov\/media\/153912\/download."},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035389"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abm0620"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0320434"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2025.2223"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00320-6"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.02.065"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2022.100600"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2022.100442"},{"key":"e_1_3_3_20_1","unstructured":"Health Sciences Authority Singapore. HSA\u2019s COVID-19 vaccine safety update #11 (30 December 2020\u201328 February 2022). 2022 [accessed 2025 Oct 24]. https:\/\/www.hsa.gov.sg\/Docs\/Default-Source\/Hprg-Vcb\/Safety-Update-On-Covid19-Vaccines\/Hsa-Safety-Update-No-11-On-Covid-19-Vaccines-(28-February-2022).Pdf."},{"key":"e_1_3_3_21_1","unstructured":"Therapeutic Goods Association. COVID-19 vaccine weekly safety report \u2013 02-12-2021: Department of Health Disability and Ageing. 2021. https:\/\/www.tga.gov.au\/news\/covid-19-vaccine-safety-reports\/covid-19-vaccine-weekly-safety-report-02-12-2021."},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.24171\/j.phrp.2021.0310"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00054-8"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40801-023-00355-5"},{"key":"e_1_3_3_25_1","volume-title":"Guidelines for preparing core clinical-safety information on drugs","author":"Council for International Organizations of Medical Sciences","year":"2001","unstructured":"Council for International Organizations of Medical Sciences. Guidelines for preparing core clinical-safety information on drugs. 2nd ed. Geneva: Council for International Organizations of Medical Sciences; 2001. https:\/\/cioms.ch\/wp-content\/uploads\/2018\/03\/Guidelines-for-Preparing-Core-Clinical-Safety-Info-Drugs-Report-of-CIOMS-Working-Group-III-and-V.pdf.","edition":"2"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae067"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2024.2397026"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.056817"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2022.12.003"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.951314"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.24110"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwad058"},{"key":"e_1_3_3_33_1","unstructured":"European Medicines Agency. Spikevax (previously COVID-19 vaccine Moderna). 2025 [accessed 2025 Aug 18]. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/spikevax."},{"key":"e_1_3_3_34_1","unstructured":"World Health Organization. COVID-19 global risk assessment. 2025 [accessed 2025 Feb 6]. https:\/\/www.who.int\/publications\/m\/item\/covid-19-global-risk-assessment."},{"key":"e_1_3_3_35_1","unstructured":"World Health Organization. COVID-19 advice for the public: getting vaccinated. 2024 [accessed 2024 Oct 8]. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/covid-19-vaccines\/advice."},{"key":"e_1_3_3_36_1","unstructured":"World Health Organization. WHO COVID-19 dashboard. 2025. https:\/\/data.who.int\/dashboards\/covid19\/vaccines\/."},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00084-18"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1562179"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S406601"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1787\/c7467f62-en"},{"key":"e_1_3_3_41_1","unstructured":"Public Health Agency of Canada. Vaccine spotlight report: a compilation of initiatives to explore vaccine uptake in the Asia-Pacific region. Ottawa (ON): Asia-Pacific Economic Cooperation Secretariat; 2024."},{"key":"e_1_3_3_42_1","doi-asserted-by":"crossref","DOI":"10.56759\/ocef1297","volume-title":"CIOMS cumulative glossary with a focus on pharmacovigilance v2.3","author":"Council for International Organizations of Medical Sciences","year":"2025","unstructured":"Council for International Organizations of Medical Sciences. CIOMS cumulative glossary with a focus on pharmacovigilance v2.3. Geneva, Switzerland: CIOMS. 2025. https:\/\/cioms.ch\/wp-content\/uploads\/2025\/07\/CIOMS_CumulativeGlossary_v2.3_Jul2025.pdf."},{"key":"e_1_3_3_43_1","unstructured":"National Health and Medical Research Council. Australian immunisation handbook: Australian Government Department of Health and Ageing. 2026 Jan [accessed 2025 May 2]. https:\/\/immunisationhandbook.health.gov.au\/contents\/vaccination-procedures\/after-vaccination."},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10122041"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.2023.J002"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.3345\/cep.2022.00815"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10071115"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.24171\/j.phrp.2024.0194"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12020149"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2025.106447"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106346"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2022.2093722"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10091461"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-90787-6"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.18502\/ijph.v51i11.11167"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10122017"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11071160"},{"issue":"2","key":"e_1_3_3_58_1","first-page":"9","article-title":"Reactogenicity of heterologous mRNA-based COVID-19 vaccine booster in young adults in Indonesia \u2013 a short communication","volume":"17","author":"Suryadinata N","year":"2023","unstructured":"Suryadinata N, Christopher PM, Imanuelly M, Wijaya RS, Cucunawangsih C, Lugito NPH. Reactogenicity of heterologous mRNA-based COVID-19 vaccine booster in young adults in Indonesia \u2013 a short communication. Afr J Infect Dis. 2023;17(2):9\u201313.","journal-title":"Afr J Infect Dis"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11030553"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvacx.2024.100516"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.127383"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08743-6"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01527-y"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01739-w"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11121772"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12060591"},{"key":"e_1_3_3_67_1","unstructured":"Korean Disease Control and Prevention Agency. COVID-19 vaccination adverse events status report (week 205). 2025."},{"key":"e_1_3_3_68_1","unstructured":"Ministry of Health Labour and Welfare Japan. The 106th adverse reaction review subcommittee of the immunization and vaccine subcommittee of the Health Sciences Council the 1st FY 2025 safety measures Investigation committee of the drug safety measures subcommittee of the pharmaceutical affairs Council. Reports of suspected side effects of COVID-19 vaccines. 2025."},{"key":"e_1_3_3_69_1","unstructured":"World Health Organization. The 58th subcommittee on vaccinations and vaccines of the Health and Science Council. Report on COVID-19 vaccine administration. 2024."},{"key":"e_1_3_3_70_1","unstructured":"World Health Organization. Causality assessment of an adverse event following immunization (AEFI): user manual for the revised WHO classification. 2nd ed. 2018 [accessed 2025 Sep 16]. https:\/\/iris.who.int\/handle\/10665\/259959."},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.11.074"},{"key":"e_1_3_3_72_1","unstructured":"Therapeutic Goods Association. COVID-19 vaccine safety report \u2013 02-11-23. 2023. https:\/\/www.tga.gov.au\/news\/covid-19-vaccine-safety-reports\/covid-19-vaccine-safety-report-02-11-23."},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2023.100885"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad339"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2024.03.026"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11040749"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.126356"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.02.032"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7130a4"},{"key":"e_1_3_3_80_1","unstructured":"AusVaxSafety. COVID-19 vaccine safety data \u2013 at a glance: AusVaxSafety. 2024 [accessed 2024 Nov 11]. https:\/\/ausvaxsafety.org.au\/vaccine-safety-data\/covid-19-vaccines."},{"key":"e_1_3_3_81_1","unstructured":"World Health Organization. Brief overview of anaphylaxis as an adverse event following immunization (AEFI) and practical guidance on its identification case management and response in a primary care setting. 2021. https:\/\/iris.who.int\/bitstream\/handle\/10665\/342195\/9789240028074-eng.pdf?sequence=1."},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2023.11.005"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac446"},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102809"},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01206-w"},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.33321\/cdi.2023.47.2"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2026.2662118","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T18:17:23Z","timestamp":1779214643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2026.2662118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/21645515.2026.2662118"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2026.2662118","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-01-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2662118"}}